Pipeline Antibiotics
Infectious Disease
UnknownActive
Key Facts
About BioQ Pharma
BioQ Pharma is a commercial-stage biotech company developing and commercializing proprietary, pre-filled, ready-to-use infusion systems for hard-to-prepare drugs. Its core invenious™ platform is designed to enhance safety, sterility, and convenience while reducing medication errors and total cost of care. The company has launched its first product, Ropivacaine Readyfusor, for post-surgical pain and is building a pipeline across anesthesia, sedation, antibiotics, and oncology.
View full company profileTherapeutic Areas
Other Infectious Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| Vaccine Platform | Biolingus | Research |
| Antivirals Platform | Qubit Pharmaceuticals | Discovery |
| Antibiotic Development Program | AF ChemPharm | Pre-clinical |
| Prophylactic Vaccine Development | ImmuneSpec | Service |
| Optimized VHH vs. SARS-CoV-2 | Ordaos Bio | Pre-clinical |
| AmorphOX Vaccine | Orexo | Preclinical |
| Undisclosed Vaccine Program(s) | Brazos Biomedical | Pre-clinical |
| Undisclosed Asset 1 | Uvax Bio | Research |
| Undisclosed Asset 2 | Uvax Bio | Research |
| Undisclosed Asset 3 | Uvax Bio | Research |
| Vaccine Immune Response (SARS-CoV-2) | CellChorus | Preclinical |
| POCKIT™ Central COVID-19 Assay | GeneReach Biotechnology | commercial |